Corvus Pharmaceuticals
CRVS
#6513
Rank
โ‚น75.58 B
Marketcap
โ‚น896.02
Share price
-3.40%
Change (1 day)
16.70%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2026 (TTM): -โ‚น5 Billion

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น1.42 Billion, an increase over its 2024 earnings that were of -โ‚น5.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น5 Billion252.58%
2025 -โ‚น1.42 Billion-75.47%
2024 -โ‚น5.78 Billion130.47%
2023 -โ‚น2.51 Billion-34.57%
2022 -โ‚น3.83 Billion-4.47%
2021 -โ‚น4.01 Billion621.28%
2020 -โ‚น0.56 Billion-87.16%
2019 -โ‚น4.33 Billion-0.57%
2018 -โ‚น4.35 Billion-15.67%
2017 -โ‚น5.16 Billion53.03%
2016 -โ‚น3.38 Billion16.08%
2015 -โ‚น2.91 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.47 Billion 188.45%๐Ÿ‡บ๐Ÿ‡ธ USA